DRREDDY had a positive weekly return of 1.22%, outperforming its peers DIVISLAB, SUNPHARMA, and HINDUNILVR. The stock's volatility was relatively high at 15.11%, indicating a moderate level of risk. Despite this, its Sharpe Ratio of 0.32 suggests that the return was somewhat justified by the risk taken. Overall, DRREDDY's performance was relatively strong this week, but investors should be cautious of the potential for future drawdowns.

[Volatility: 15.11%]